Literature DB >> 18577653

Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.

M Ueta1, C Sotozono, T Inatomi, K Kojima, J Hamuro, S Kinoshita.   

Abstract

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute severe blistering diseases of the skin and also two of the most devastating ocular surface diseases leading to corneal damage and loss of vision. The extreme rarity of cutaneous and ocular surface reactions to drug therapies led us to suspect individual susceptibility. SJS/TEN patients in the acute stage were reported to manifest increased serum levels of Fas Ligand (FasL). Thus, we performed SNP association analysis of the FasL gene.
METHODS: In 76 Japanese SJS/TEN patients with ocular surface complications and 160 Japanese healthy controls, we examined four SNPs of FasL reported in the Japanese Single Nucleotide Polymorphisms (JSNP) database by sequencing.
RESULTS: The SNP rs.3830150 A/G showed a significant strong inverse association with SJS/TEN. Analysis of the genotype pattern of SNPs rs.3830150 and rs.2639614 (rs.3830150 A/A-rs.2639614 G/G) also manifested a strong inverse association with SJS/TEN.
CONCLUSION: FasL gene polymorphisms might be associated with SJS/TEN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577653     DOI: 10.1136/bjo.2007.136796

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

Review 1.  Innate immunity of the ocular surface.

Authors:  Shigeru Kinoshita; Mayumi Ueta
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

2.  Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.

Authors:  Suran L Fernando; Andrew J Broadfoot
Journal:  CMAJ       Date:  2009-11-23       Impact factor: 8.262

3.  Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.

Authors:  Tais H Wakamatsu; Mayumi Ueta; Katsushi Tokunaga; Yukinori Okada; Renata R Loureiro; Karita A Costa; Juliana Maria F Sallum; José Arthur Milhomens; Chikara Inoue; Chie Sotozono; José Álvaro P Gomes; Shigeru Kinoshita
Journal:  JAMA Ophthalmol       Date:  2017-04-01       Impact factor: 7.389

4.  Cutaneous drug hypersensitivity: immunological and genetic perspective.

Authors:  Kisalay Ghosh; Gautam Banerjee; Asok Kumar Ghosal; Jayoti Nandi
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

5.  Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.

Authors:  Ken Nakatani; Mayumi Ueta; Seik-Soon Khor; Yuki Hitomi; Yuko Okudaira; Anri Masuya; Yuki Wada; Chie Sotozono; Shigeru Kinoshita; Hidetoshi Inoko; Katsushi Tokunaga
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

6.  HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens-Johnson syndrome with severe ocular surface complications.

Authors:  Mayumi Ueta; Katsushi Tokunaga; Chie Sotozono; Hiromi Sawai; Gen Tamiya; Tsutomu Inatomi; Shigeru Kinoshita
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 7.  Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions.

Authors:  Mayumi Ueta
Journal:  Taiwan J Ophthalmol       Date:  2016-08-06

8.  The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

Authors:  Shang-Chen Yang; Sindy Hu; Sheng-Zheng Zhang; Jin-Wen Huang; Jing Zhang; Chao Ji; Bo Cheng
Journal:  J Immunol Res       Date:  2018-02-11       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.